nutrafoods-international-journal-logo-80nutrafoods-international-journal-logo-80nutrafoods-international-journal-logo-80nutrafoods-international-journal-logo-80
  • HOME
  • NUTRAFOODS BOARD
  • ARTICLES
  • SUBMIT A MANUSCRIPT
  • CHECK STATUS

The use of high-dose omega-3 fatty acids in the management of cardiovascular disease

High-dose omega-3 fatty acids rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can have significant benefits in the management of cardiovascular disease due to their formation of specialized hormones known as resolvins. The appropriate dose can be determined by the ratio of arachidonic acid (AA) to EPA in the blood. This review will summarize the recent data on reducing the AA/EPA ratio and its effects on cardiovascular outcomes.

DOI: 10.17470/NF-017-1018-1

DATE: 2018

AUTHOR/S: Sears B

ABSTRACT:
High-dose omega-3 fatty acids rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can have significant benefits in the management of cardiovascular disease due to their formation of specialized hormones known as resolvins. The appropriate dose can be determined by the ratio of arachidonic acid (AA) to EPA in the blood. This review will summarize the recent data on reducing the AA/EPA ratio and its effects on cardiovascular outcomes.

KEYWORDS:
Omega-3 fatty acids Cardiovascular diseases Resolvins Omega-3 index, AA / EPA ratio

 

Download Article

Find a Specific Article

Find by Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016


ISSN 2240-5291 (electronic edition)

EDITORIAL INFORMATION

Editor-in-Chief
Francesco Di Pierro

Journal Office
Anna Lebovich

Mail: info@nutrafoods.eu

Copyright 2019 – Nutrafoods.eu

International Journal on Nutraceuticals, Functional Foods and Novel Foods
- from Research to Industrial Applications -


Privacy Policy  |  Cookies Policy
WebMaster KosmoSol
 
      By continuing to browse the site you are agreeing to our use of cookies.